Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Norway Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20071
20091
20122
20131
20142
20151
20181
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Eli Lilly and Company3
AstraZeneca2
Novartis Pharmaceuticals2
AbbVie1
Astellas Pharma Europe Ltd.1
Bristol-Myers Squibb1
Cogent Biosciences, Inc.1
Pfizer1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis17
Neoplasms4
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Melanoma3
Neoplasms by Site3
Brain Neoplasms2
Breast Diseases2
Colorectal Neoplasms2
Prostatic Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.